Iproteos SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Iproteos SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11249
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Iproteos SL (Iproteos) is a biotechnology company that develops therapeutic drugs for human diseases. The company develops drugs to treat various therapeutic indications such as cognitive impairment associated with schizophrenia, epilepsy, paediatric cancer, and others. It provides research and development of novel therapeutic strategies based on modulation of protein-ligand and protein-protein interactions through peptidomimetics. Iproteos utilizes its IPROTech, an in-house technology platform which is used to discover new peptidomimetic drugs for several targets. The company works in collaboration with universities, research centres and pharmaceutical and biotechnology companies to design novel peptidomimetic drugs. Iproteos is headquartered in Barcelona, Spain.

Iproteos SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Iproteos SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Iproteos SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Iproteos SL, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Iproteos Raises USD1.6 Million in Venture Financing 10
Iproteos Raises USD0.1 Million in Equity Crowdfunding 11
Iproteos Raises Funds through Equity Crowdfunding 12
Iproteos SL – Key Competitors 13
Iproteos SL – Key Employees 14
Iproteos SL – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Iproteos SL, Pharmaceuticals & Healthcare, Key Facts 2
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Iproteos SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Iproteos SL, Deals By Therapy Area, 2012 to YTD 2018 8
Iproteos SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Iproteos Raises USD1.6 Million in Venture Financing 10
Iproteos Raises USD0.1 Million in Equity Crowdfunding 11
Iproteos Raises Funds through Equity Crowdfunding 12
Iproteos SL, Key Competitors 13
Iproteos SL, Key Employees 14

List of Figures
Iproteos SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Iproteos SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Iproteos SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Iproteos SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Entek Energy Ltd (ETE):石油・ガス:M&Aディール及び事業提携情報
    Summary Entek Energy Limited (Entek Energy) is an upstream energy company that carries out the exploration, production and development of oil and gas reserves in addition to investment in the energy resources industry. It acquires oil and gas assets and explores conventional and unconventional sourc …
  • Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • Svenska Cellulosa Aktiebolaget:企業の戦略・SWOT・財務情報
    Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Selexys Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Selexys Pharmaceuticals Corp (Selexys Pharmaceuticals) is a biopharmaceutical company that develops drugs for the treatment of inflammatory and thrombotic diseases. The company’s products comprise Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • GlaxoSmithKline Pharmaceuticals Ltd (GLAXO):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …
  • Wolfgang Puck Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • S&T Bancorp Inc:企業の戦略・SWOT・財務情報
    S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary S&T Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • HCA Healthcare Inc (HCA)-製薬・医療分野:企業M&A・提携分析
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • American Dental Partners Inc:企業の戦略的SWOT分析
    American Dental Partners Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Biotec Pharmacon ASA (BIOTEC):医療機器:M&Aディール及び事業提携情報
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆